An analysis of Medicare Part D data reveals that a preference among eye care providers for name-brand medication has systemwide cost implications.
Kellogg Eye Center
A newly approved stent designed to treat glaucoma is a new option for some patients at U-M’s Kellogg Eye Center, one of the first centers in the country to offer it.
Ophthalmologists urge providers to stop prescribing antibiotics for a common eye condition that typically clears up without medication.
A study drug safely minimizes severity for those with a painful eye condition, a new clinical trial at the University of Michigan Kellogg Eye Center has found.
Quick surveys before eye health appointments could help clinicians target care and improve record-keeping, a Michigan Medicine study finds.
Not all hospitals have the clinicians to diagnose and treat an eye disease in premature babies. But they can use technology to connect with ophthalmologists elsewhere.